Potent and selective CDK 4/6 inhibitor1. Mitigates acute kidney injury. Induces cell cycle arrest and senescence in neuroblastoma. In clinical use for HR-positive, HER2-negative metastatic breast cancer. Orally bioavailable
Know who made it. See the evidence. Buy through one marketplace.
Potent and selective CDK 4/6 inhibitor1. Mitigates acute kidney injury. Induces cell cycle arrest and senescence in neuroblastoma. In clinical use for HR-positive, HER2-negative metastatic breast cancer. Orally bioavailable
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
